Medicine & Life Sciences
Leukemia, Myelomonocytic, Chronic
100%
Survival
96%
Follicular Lymphoma
94%
Hairy Cell Leukemia
93%
Immunophenotyping
92%
Primary Myelofibrosis
91%
Lymphoma
90%
T-Cell Lymphoma
90%
Chromosomes, Human, Pair 7
87%
Myelodysplastic Syndromes
86%
Rituximab
74%
Cell Transplantation
73%
Non-Hodgkin's Lymphoma
72%
pidilizumab
72%
Mutation
72%
Glioma
63%
Multicenter Studies
59%
Stem Cell Transplantation
56%
Acute Myeloid Leukemia
54%
Peripheral T-Cell Lymphoma
54%
Phenotype
54%
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
53%
Anaplastic Large-Cell Lymphoma
52%
nucleophosmin
50%
Flow Cytometry
49%
GATA2 Deficiency
47%
CD8 Antigens
47%
Lenalidomide
45%
Neoplasms
45%
Hemophagocytic Lymphohistiocytosis
45%
Cutaneous T-Cell Lymphoma
44%
Sequence Deletion
43%
CD4 Antigens
43%
Chromosome Aberrations
43%
Gefitinib
42%
Neoplasm Metastasis
42%
B-Lymphocytes
40%
Gene Amplification
39%
Safety
39%
DNA Nucleotidylexotransferase
39%
Manuscripts
39%
Lymphoma, Large B-Cell, Diffuse
38%
Bone Marrow
38%
Autologous Transplantation
38%
Anaplastic Lymphoma Kinase
38%
p53 Genes
37%
Cytogenetics
37%
Body Fluids
37%
Pituitary Neoplasms
37%
Sclerosis
36%